DAXXIFY Trademark

Trademark Overview


On Thursday, February 23, 2023, a trademark application was filed for DAXXIFY with the United States Patent and Trademark Office. The USPTO has given the DAXXIFY trademark a serial number of 97809052. The federal status of this trademark filing is REGISTERED as of Tuesday, June 17, 2025. This trademark is owned by Revance Therapeutics, Inc.. The DAXXIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
daxxify

General Information


Serial Number97809052
Word MarkDAXXIFY
Filing DateThursday, February 23, 2023
Status700 - REGISTERED
Status DateTuesday, June 17, 2025
Registration Number7836568
Registration DateTuesday, June 17, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 14, 2023
Primary Code005
First Use Anywhere DateMonday, September 26, 2022
First Use In Commerce DateSaturday, September 30, 2023

Trademark Owner History


Party NameRevance Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGLENGORMLEY BT365EB
GB

Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Monday, February 27, 2023NEW APPLICATION ENTERED
Tuesday, March 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 21, 2023ASSIGNED TO EXAMINER
Monday, November 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 1 GRANTED
Thursday, February 20, 2025USE AMENDMENT FILED
Thursday, February 20, 2025TEAS STATEMENT OF USE RECEIVED
Friday, May 9, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 12, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 27, 2024SOU EXTENSION 1 FILED
Friday, May 23, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 17, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, June 17, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, May 23, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED